Although all studies were unclear on the blinding of outcome assessment, patients with endometriosis have objective evaluation indexes for recurrence, pregnancy and serum CA-125 level, and it was difficult to affect the outcomes evaluation. The gene discussed is MUC16; the disease is endometriosis.